(Q44360127)

English

Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial).

scientific article published on 17 August 2013

Statements

Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial). (English)
M Neil Reaume
Natasha B Leighl
Nicole Mittmann
Vera Hirsh
Lesley Seymour
Dongsheng Tu
Frances A Shepherd
Barbara Graham
Francesco Perrone
Massimo Di Maio
Penelope A Bradbury
William K Evans
17 August 2013
115-120

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit